Comparison of Intranasal and Injectable Glucagon Administration Among Pediatric Population Responders-Reference-Cited by-同舟云学术

Comparison of Intranasal and Injectable Glucagon Administration Among Pediatric Population Responders

Published:2023-11-01 Issue:11 Volume:25 Page:808-816
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Wang Yue-Pei¹^ORCID,Bernatchez Francesca²,Chouinard-Castonguay Sarah¹,Tremblay Marie-Claude²³,Vanasse Andréane⁴,Kinnard Nathalie⁴,Mégalli Mélissa¹,Millette Maude⁵,Boulet Geneviève⁶,Henderson Mélanie⁷⁸⁹,Simoneau-Roy Judith¹⁰,Brazeau Anne-Sophie¹¹^ORCID,Rabasa-Lhoret Rémi¹²^ORCID,Gagnon Claudia¹⁶^ORCID

Affiliation:

1. CHU de Québec—Université Laval Research Centre, Centre Hospitalier de l'Université Laval, Quebec, Canada.

2. Department of Family Medicine and Emergency Medicine, Université Laval, Quebec, Canada.

3. VITAM, Sustainable Health Research Centre, Quebec, Canada.

4. Patient Partners of the BETTER Registry for Type 1 Diabetes, Quebec, Canada.

5. Department of Pediatrics, Université Laval, Quebec, Canada.

6. Department of Medicine, Université Laval, Quebec, Canada.

7. Department of Pediatrics, Université de Montréal, Montreal, Canada.

8. CHU Ste-Justine Research Center, Montreal, Canada.

9. Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, Canada.

10. Department of Pediatrics, Endocrinology Division, Faculty of Medicine and Health Sciences, CIUSSS-Estrie CHUS, Université de Sherbooke, Sherbrooke, Canada.

11. School of Human Nutrition, McGill University, Montreal, Canada.

12. Faculty and Department of Medicine, Clinical Research Institute of Montreal, Université de Montréal, Montreal, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0290

Reference39 articles.

1. Epidemiology of Type 1 Diabetes

2. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial

3. Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration

4. A contrast between children and adolescents with excellent and poor control: the T1D exchange clinic registry experience

5. Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes